A study published in JAMA Cardiology Jan. 2 suggests physicians may achieve comparable results when using either radial or femoral access for primary PCI in patients with STEMI.

A hematologist-oncologist from the University of North Carolina has successfully treated a U.S. astronaut’s deep vein thrombosis in the longest telemedicine consultation to date, Forbes reported Jan. 5.

Researchers have developed a new stroke risk score that leverages genetic data to identify people at a particularly high risk of ischemic stroke.

Working long hours was linked to as much as a 70% increased risk of masked hypertension and a 66% greater risk of sustained hypertension in a recent study of 3,500 white-collar employees in Quebec, Canada.

A study published in JAMA Internal Medicine last month found that direct oral anticoagulants were more effective in minimizing AFib patients’ risk of experiencing fracture than warfarin, supporting the theory that the blood thinner might be harmful to bone health.

An AI algorithm that reportedly helps physicians identify reduced left ventricular ejection fraction (LVEF) received Breakthrough Device designation from the FDA on Dec. 18.

Research led by a team at the University of Kentucky and funded by the American Heart Association and National Institutes of Health has uncovered a new biomarker for cardiovascular disease: an apolipoprotein/antibody combo.

Researchers at the University of Houston are pioneering a unique method for developing biological pacemakers: converting stem cells found in fat to biologic pacemaker cells.

Switching to a healthier diet could save Americans more than $300 annually and could cut U.S. healthcare costs by $50 billion, a new study suggests.

Hepatitis C-positive donor hearts are a viable long-term option for patients in need of a heart transplant, researchers confirmed in JAMA Cardiology Dec. 18.